市場調査レポート
商品コード
1424848
末梢塞栓防止装置市場:セグメント別規模、シェア、法規制、償還、手技、2033年までの予測Peripheral Embolic Protection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
末梢塞栓防止装置市場:セグメント別規模、シェア、法規制、償還、手技、2033年までの予測 |
出版日: 2024年01月09日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
プラークの蓄積による動脈の狭窄は、末梢血管疾患、頸動脈狭窄、腎動脈狭窄などの病態で発生します。血管形成術は、正常な血流を回復させるために、プラークが過剰に蓄積した動脈の閉塞を解除するために用いられる低侵襲のインターベンション手技です。血管形成術の手技中に塞栓の破片が外れることがあり、そのままにしておくと肺塞栓症を引き起こす可能性があります。遠位塞栓事象から保護するために、EPDはインターベンション手技中に外れる可能性のある破片を捕捉・除去するように設計されています。現在の塞栓防止装置(EPD)の技術は、遠位閉塞、近位閉塞、遠位濾過という3つの重要な戦略を採用しています。
当レポートは、世界の末梢塞栓防止装置市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Peripheral Embolic Protection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Peripheral Embolic Protection Devices market for the year 2020 and beyond. A narrowing of arteries due to the build-up of plaque occurs in conditions such as peripheral vascular disease, carotid artery stenosis and renal artery stenosis. Angioplasty is a minimally invasive interventional procedure that is used to unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures, which if left alone can cause a pulmonary embolism. To protect against distal embolic events, EPD are designed to capture and remove debris that may get dislodged during interventional procedures. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Cordis Corp, Cardiovascular Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable